Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates

BACKGROUND: Candida infections are common and often fatal in infants and neonates. Anidulafungin has excellent activity against Candida sp, but unknown pharmacokinetics and safety in infants and neonates. OBJECTIVE: Determine the pharmacokinetics and safety of anidulafungin in infants and neonates a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cohen-Wolkowiez, Michael, Benjamin, Daniel K., Piper, Lauren, Cheifetz, Ira M., Moran, Cassandra, Liu, Ping, Aram, Jalal, Kashuba, Angela DM, Capparelli, Edmund, Walsh, Thomas J., Hope, William W., Smith, P. Brian
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3124385/
https://ncbi.nlm.nih.gov/pubmed/21412233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.26
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak